Merck Mergers and Acquisitions Summary

Life ScienceCompany

Merck has acquired 29 companies, including 16 in the last 5 years. A total of 8 acquisitions came from private equity firms. It has also divested 7 assets.

Merck’s largest acquisition to date was in 2009, when it acquired Schering-Plough for $41.1B. It’s largest disclosed sale occurred in 2009, when it sold Merial to Sanofi SA for $4.0B. Merck has acquired in 10 different US states, and 7 countries. The Company’s most targeted sectors include life science (90%) and information technology (4%).

Join Mergr and gain access to Merck’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

M&A Summary

  • M&A Total Activity35
    • M&A Buy Activity28
    • M&A Sell Activity7
  • Total Sectors Invested 4
  • Total Countries Invested 7
  • M&A Buy/Sell Connections 15
  • M&A Advisors 11

Merck

Merck & Co., Inc.

2000 Galloping Hill Road,
Kenilworth, New Jersey 07033
United States,
(908) 423-1000
www.merck.com

Merck is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The Company’s operations are comprised of four operating segments. These include Pharmaceutical, Animal Health, Consumer Care and Alliances. Merck's Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices. The Company also has animal health operations that discover, develop, manufacture and market animal health products, including vaccines, which the Company sells to veterinarians, distributors and animal producers. Additionally, the Company has consumer care operations that develop, manufacture and market over-the-counter, foot care and sun care products. Merck was established in 1891 and is based in Kenilworth, New Jersey.


M&A Summary

Buy vs Sell

Year ≤ '16 '17 '18 '19 '20 '21 T
Buy (2.4/yr) # 16 - 2 4 4 2 28
vol $63.5B $2.7B $4.2B $3.6B $13.4B $87.3B
Sell (0.6/yr) # 4 - 1 - 1 1 7
vol $4.1B $4.1B
  35

Most Recent M&A

Company Date Value Type
Acceleron Pharma, Inc. 2021-09-30 11.5B USD Add-on Acquisition
Cambridge, Massachusetts · ww.acceleronpharma.com
Organon & Co. 2021-06-03 - Spin Off
Jersey City, New Jersey · www.organon.com
Pandion Therapeutics, Inc. 2021-02-25 1.9B USD Add-on Acquisition
Watertown, Massachusetts · www.pandiontx.com
OncoImmune 2020-11-23 425M USD Add-on Acquisition
Rockville, Maryland · www.oncoimmune.com
VelosBio, Inc. 2020-11-05 2.8B USD Add-on Acquisition
San Diego, California · www.velosbio.com
Themis Bioscience GmbH 2020-05-26 - Add-on Acquisition
Vienna, Austria · www.themisbio.com
Virbac SA - SENTINEL U.S. Rights 2020-05-13 400M USD Divestiture
, New Jersey
The StayWell Company 2020-03-12 - Divestiture
Yardley, Pennsylvania · www.staywell.com
ArQule, Inc. 2019-12-09 2.7B USD Add-on Acquisition
Burlington, Massachusetts · www.arqule.com
Tilos Therapeutics, Inc. 2019-06-10 - Add-on Acquisition
Lexington, Massachusetts · www.tilostherapeutics.com
View All >>

Business Unit M&A

Company Acquired Add-On/Sale Date #
Merck Sharp & Dohme B.V.    - Vree Health LLC 2015-10-21 3
Haarlem, Netherlands · www.msd.nl Annandale, New Jersey · www.vreehealth.com
Merck Animal Health    - Global Animal Management Inc. 2014-02-28 1
Madison, New Jersey · www.merck-animal-health-usa.com , United States
Merck Sharp & Dohme B.V.    - Saphris 2013-12-02 2
Haarlem, Netherlands · www.msd.nl , United States
Merck Sharp & Dohme B.V.    - Merck Sharp & Dohme - Pharma­ceutical Skin Care Product(Propyless) 2013-11-08 1
Haarlem, Netherlands · www.msd.nl , Sweden
Rosetta Inpharmatics, Inc. 2001-05-11 Rosetta Biosoftware 2009-06-01 1
Kirkland, Washington · www.rii.com Seattle, Washington · www.rosettabio.com

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 25 (89%) 84.9B (97%) 2 (29%) 75M (2%)
Information Technology 1 (4%) - 1 (14%) -
Publishing 1 (4%) - 1 (14%) -
Test/Measurement Equipment 1 (4%) 2.4B (3%) - -
Business Services - - 1 (14%) -
Healthcare Services - - 1 (14%) -
Medical Products - - 1 (14%) 4.0B (98%)
Total 28 $87.3B 7 $4.1B

By Geo

State/Country Buy Value Sell Value
United States 22 84.4B 7 4.1B
  Massachusetts 7 29.9B - -
  New Jersey 3 47.5B 2 -
  California 4 3.7B - -
  Pennsylvania 1 - 2 -
  Washington 2 920M - -
  Wisconsin 1 - - -
  Texas 1 1.2B - -
  North Carolina 1 430M - -
  New Hampshire 1 400M - -
  Maryland 1 425M - -
  Georgia - - 1 4.0B
Australia 1 357M - -
Austria 1 - - -
Canada 1 - - -
  Quebec 1 - - -
France 1 2.4B - -
Switzerland 1 110M - -
United Kingdom 1 - - -
Domestic 22 (79%) 84.4B (97%) 7 (100%) 4.1B (100%)
Cross-border 6 (21%) 2.8B (3%) - -
Total 28 $87.3B 7 $4.1B

Top M&A Advisors

Financial Deals
Credit Suisse Investment Banking
5
J.P. Morgan Securities LLC
2
Barclays Investment Bank
1
Legal Deals
Covington & Burling LLP
4
Gibson, Dunn & Crutcher LLP
3
Baker & McKenzie LLP
2

Deal Values

buy # Total
> $1B 10 $82.8B
$100M to $1B 11 $4.4B
< $100M 1 $80M
TOTAL $87.3B
Largest Schering-Plough Corp.
$41.1B (2009-11-03)
sell # Total
> $1B 1 $4.0B
< $100M 1 $75M
TOTAL $4.1B
Largest Merial Ltd.
$4.0B (2009-07-30)

M&A Connections

Deals
Acquired from
Investor(s)
25%
7 (25%)
Strategic(s)
4%
1 (4%)
Divested to
Strategic(s)
86%
6 (86%)

 Subscribe to unlock this and 171,700
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.2K Private Equity Firms
  • 161K M&A Transactions
  • 167K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.4K M&A Advisors
    (Investment Banks and Law Firms)
  • 59K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.